This is the first approved agent in a new class of antihyperglycemics ... the primary enzyme degrading the incretin hormones, allowing glucagon-like peptide-1 and glucose-dependent insulinotropic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback